Zobrazeno 1 - 10
of 1 220
pro vyhledávání: '"alpha-cells"'
Autor:
Jordan Carroll, Jessie Chen, Rahul Mittal, Joana R. N. Lemos, Mannat Mittal, Shreya Juneja, Amro Assayed, Khemraj Hirani
Publikováno v:
Cells, Vol 13, Iss 22, p 1914 (2024)
Alpha cells in the pancreas, traditionally known for their role in secreting glucagon to regulate blood glucose levels, are gaining recognition for their involvement in the pathophysiology of type 1 diabetes (T1D). In T1D, autoimmune destruction of b
Externí odkaz:
https://doaj.org/article/540fc38ccca4484baae854cea78260eb
Autor:
Nirmala V. Balasenthilkumaran, Jennifer C. Whitesell, Laura Pyle, Rachel S. Friedman, Vira Kravets
Publikováno v:
Frontiers in Network Physiology, Vol 4 (2024)
One of the challenges in studying islet inflammation–insulitis–is that it is a transient phenomenon. Traditional reporting of the insulitis progression is based on cumulative, donor-averaged values of leucocyte density in the vicinity of pancreat
Externí odkaz:
https://doaj.org/article/fc353adb09c34af7af45bfa39518745e
Autor:
Aedan Brown, Emmanuel S. Tzanakakis
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionBlood sugar homeostasis relies largely on the action of pancreatic islet hormones, particularly insulin and glucagon. In a prototypical fashion, glucagon is released upon hypoglycemia to elevate glucose by acting on the liver while elevat
Externí odkaz:
https://doaj.org/article/fde32a3eb02a469db56b0f21d384fe90
Autor:
Bibi Uhre Nielsen, Inger Hee Mabuza Mathiesen, Rikke Møller, Rikke Krogh-Madsen, Terese Lea Katzenstein, Tacjana Pressler, James A. M. Shaw, Christian Ritz, Michael R. Rickels, Darko Stefanovski, Thomas Peter Almdal, Daniel Faurholt-Jepsen
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
AimsThe purpose of the study was to further elucidate the pathophysiology of cystic fibrosis (CF)-related diabetes (CFRD) and potential drivers of hypoglycaemia. Hence, we aimed to describe and compare beta cell function (insulin and proinsulin) and
Externí odkaz:
https://doaj.org/article/88132567683d426abc643eb60765c95a
Autor:
Marija Đorđević, Peter Stepper, Clarissa Feuerstein-Akgoz, Clarissa Gerhauser, Verica Paunović, Anja Tolić, Jovana Rajić, Svetlana Dinić, Aleksandra Uskoković, Nevena Grdović, Mirjana Mihailović, Renata Z. Jurkowska, Tomasz P. Jurkowski, Jelena Arambašić Jovanović, Melita Vidaković
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionBeta cell dysfunction by loss of beta cell identity, dedifferentiation, and the presence of polyhormonal cells are main characteristics of diabetes. The straightforward strategy for curing diabetes implies reestablishment of pancreatic be
Externí odkaz:
https://doaj.org/article/366d6c80f48f4fac8cb7a3ddf9cb8ff4
Autor:
Aneta M. Dobosz, Justyna Janikiewicz, Ewelina Krogulec, Anna Dziewulska, Anna Ajduk, Marcin Szpila, Hanna Nieznańska, Andrzej A. Szczepankiewicz, Dorota Wypych, Agnieszka Dobrzyn
Publikováno v:
Molecular Metabolism, Vol 67, Iss , Pp 101659- (2023)
Abnormalities that characterize the pathophysiology of type 2 diabetes (T2D) include deficiencies of β-cells and the expansion of α-cells in pancreatic islets, manifested by lower insulin release and glucagon oversecretion. The molecular mechanisms
Externí odkaz:
https://doaj.org/article/93b47b0cfaee40919c316cd1cf33440e
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Type 1 Diabetes (T1D) is caused by insulin deficiency, due to progressive autoimmune destruction of pancreatic β cells. Glucagon-secreting α cells become dysfunctional in T1D and contribute to pathophysiology, however, the mechanisms involved are u
Externí odkaz:
https://doaj.org/article/cf42848ddf564ac6977a7bfc049dfb54
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Diabetes is defined by hyperglycaemia due to progressive insulin resistance and compromised insulin release. In parallel, alpha cells develop dysregulation of glucagon secretion. Diabetic patients have insufficient glucagon secretion during hypoglyca
Externí odkaz:
https://doaj.org/article/2717611efa544c31b6e26b58003e2416
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.